Drug susceptibility to etravirine and darunavir among Human Immunodeficiency Virus Type 1-derived pseudoviruses in treatment-experienced patients with HIV/AIDS in South Korea

BACKGROUND: In South Korea, about 20 types of antiretroviral drugs are used in the treatment of patients with human immunodeficiency virus/acquired immune deficiency syndrome. Since 2010, raltegravir, etravirine, and darunavir have been spotlighted as new drugs for highly active antiretroviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Oh-Kyung, Kim, Sung Soon, Rhee, Jee Eun, Kee, Mee-Kyung, Park, Mina, Oh, Hye-Ri, Choi, Ju-yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404133/
https://www.ncbi.nlm.nih.gov/pubmed/25879840
http://dx.doi.org/10.1186/s12985-015-0283-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404133/
https://www.ncbi.nlm.nih.gov/pubmed/25879840
http://dx.doi.org/10.1186/s12985-015-0283-7

Ejemplares similares